Phase I clinical trial of the fifteen-valent HPV vaccine developed by Chengda Bio was officially launched.

More

Chengda Biology's First "King Hegemony" Laws and Regulations Knowledge Contest Successfully Ends

In order to stimulate employees' enthusiasm for autonomous learning of laws and regulations, enhance employees' quality awareness, professional skills and knowledge of laws and regulations, enhance teamwork ability, and promote the quality culture of the enterprise, Chengda Biological GMP Office successfully held the first "King for hegemony" legal knowledge competition team PK competition on March 11, 2024.

More

China Vaccine Industry Association Rabies Prevention and Control 2023

In order to strengthen academic exchanges in the field of prevention and treatment of animal injuries, especially after rabies exposure, the China Vaccine Industry Association Rabies Prevention and Control 2023 Conference and the 3rd Space Animal Injury Standardized Diagnosis and Treatment Training Course (Changsha Station), November 22-Held in Changsha City, Hunan Province on November 24. This conference was organized by the Rabies Prevention and Control Branch of China Vaccine Industry Association and the head of the Space Center Hospital......

More

2023 Training Course for Director of Animal Injury Department Successfully Held

More

Fast to dream, Libao future

More

The peak of Japanese encephalitis in Guangdong is coming, and the "upgraded" vaccine will be vaccinated.

More

[2023 National Children's Vaccination Day] Take the initiative to vaccinate and share a healthy life.

More

Warmly congratulate the company partner Recreation Guardian Company successfully listed on the North Stock Exchange!

More

Announcement of Liaoning Provincial Drug Administration on Entrusted Distribution and Storage of Vaccine Production Enterprises (No.17 of 2022)

More

Liaoning Chengda Bio Actively Responds to the Call of the Ministry of Commerce to Participate in Sri Lanka Aid Projects

More